PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 6, 20260 citationsOpen Access

Non-Surgical Submarginal Instrumentation of Peri-Implant Mucositis With Delivery of Sodium Hypochlorite/Amino Acids and Cross-Linked Hyaluronic Acid: A Randomized Clinical Trial.

View Full Paper
VIVincenzo Iorio-SicilianoABAndrea BlasiLMLeopoldo Mauriello

Key Points

  • To assess the effectiveness of submarginal instrumentation with or without sodium hypochlorite and hyaluronic acid in treating peri-implant mucositis.
  • Randomized clinical trial design with 40 patients diagnosed with peri-implant mucositis.
  • Two groups: one receiving submarginal instrumentation with adjunctive agents and another receiving SI alone.
  • Clinical parameters (e.g., bleeding scores and probing depth) were assessed at baseline, 3, and 6 months.
  • Both treatment groups showed statistically significant improvement in clinical parameters after 6 months (p < 0.05).
  • The test group had a 72.2% improvement in mean Bleeding on Probing (BoP) at 6 months compared to 70.0% in the control group.
  • Disease resolution in the test group correlated significantly with probing depth measurements, showing an odds ratio of 3.77 for those with deeper initial probing depths.

Abstract

Objectives To evaluate the effects of submarginal instrumentation (SI) with or without adjunctive delivery of sodium hypochlorite (NaOCl)/amino acids and cross-linked hyaluronic acid (xHyA) gel in the treatment of peri-implant mucositis (PM). Material And Methods Forty implants supporting single-unit crowns diagnosed with PM in 40 patients were randomly assigned to test (SI + NaOCl/amino acids and xHyA) or control group (SI alone). The primary outcome was mean BoP change. Full-Mouth Plaque Score (FMPS), Full-Mouth Bleeding Score (FMBS), modified plaque index (mPlI), and probing depth (PD) were assessed as secondary outcomes. Clinical parameters were assessed at baseline, 3 and 6 months. Disease resolution was also recorded. Results Two patients were lost during follow-up while 38 patients completed the study without adverse effects. After 6 months, all clinical parameters improved statistically significantly in both groups (p 0.05); conversely, an initial PD = 5 mm yielded a statistically significant difference (p < 0.05). Disease resolution correlation with test group was statistically significant with a 3.77 odds ratio. Conclusion Within the limitations of the present study, adjunctive delivery of NaOCl/amino acids and xHyA to SI yielded superior clinical outcomes compared with SI alone in the treatment of PM. Trial Registration ClinicalTrials.gov: NCT05926297.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Iorio-Siciliano et al. (2026) studied this question.

synapsesocial.com/papers/69aa705a531e4c4a9ff5a143https://doi.org/10.48620/95936
Ask AI
Helpful
Bookmark
Share
View Full Paper